Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 481 studies with search of: | "Glioblastoma" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Active, not recruiting |
Phase 1/2 Study in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients
|
||||
2 | Recruiting |
Measuring Non-Enhancing Glioblastoma Progression
|
||||
3 | Active, not recruiting |
Clinical Trial to Assess the Efficacy and Safety of 'INNOCELL Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea
|
||||
4 | Recruiting |
Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma
|
||||
5 | Recruiting |
Dose-Intense Temozolomide in Recurrent Glioblastoma
|
||||
6 | Recruiting |
Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma
|
||||
7 | Recruiting |
Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma
|
||||
8 | Recruiting |
Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma
|
||||
9 | Recruiting |
A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma
|
||||
10 | Terminated |
Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma
|
||||
11 | Not yet recruiting |
Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma
|
||||
12 | Completed |
Efficacy of Distant Healing in Glioblastoma Treatment
|
||||
13 | Recruiting |
Ketogenic Diet for Recurrent Glioblastoma
|
||||
14 | Terminated |
Radiation Boost for Newly Diagnosed Glioblastoma Multiforme
|
||||
15 | Recruiting |
PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs
|
||||
16 | Active, not recruiting |
Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme
|
||||
17 | Recruiting |
Epothilone in Recurrent Glioblastoma Patients
|
||||
18 | Not yet recruiting |
Combining Radiotherapy and Temozolomide With Dichloracetate in Patients With Newly Diagnosed Glioblastoma
|
||||
19 | Recruiting |
Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
|
||||
20 | Withdrawn |
Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme
|
Previous Page | Studies Shown (1-20) | Next (21-40) |